Contingency management for methamphetamine cessation during pregnancy: a cost-effectiveness analysis

Publication: American Journal of Obstetrics and Gynecology; January 2024

Overview:

Methamphetamine use in pregnancy is rising and is associated with increased perinatal morbidity and mortality. Contingency management (CM) programs provide financial incentives for decreased use and are one of the most effective interventions for methamphetamine cessation in the general population. However, the use of CM during pregnancy to encourage methamphetamine cessation has not yet been studied. The objective of this study is to examine the cost-effectiveness of CM programs for pregnant individuals who use methamphetamines.

Conclusion:

Contingency management for methamphetamine cessation during pregnancy is a cost-effective intervention to promote abstinence from use and reduce rates of adverse pregnancy outcomes such as preterm birth and stillbirth. Implementing these programs should be considered when caring for these patients, but will need to be proactively funded.

 


 

Citation:

Jessica D. Wallace DJ, McCarthy S, Doshi U, et al. Contingency management for methamphetamine cessation during pregnancy: a cost-effectiveness analysis. American Journal of Obstetrics and Gynecology. 2024 January;230:S337.